Related Experiment Video
Updated: May 25, 2026

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
Tracheotomy and children with spinal muscular atrophy type 1: ethical considerations in the French context
Brigitte Rul1, Franco Carnevale, Brigitte Estournet
1Raymond Poincaré Hospital, France. brigitte.rul@rpc.aphp.fr
Insights
This article analyzes the ethical considerations of providing mechanical ventilation for infants with Spinal Muscular Atrophy (SMA) type 1, a severe genetic neuromuscular disease. It explores arguments for and against invasive ventilation, particularly relevant in France.
Area of Science:
- Pediatric Neurology
- Bioethics
- Genetics
Background:
- Spinal Muscular Atrophy (SMA) type 1 is a severe genetic neuromuscular disorder affecting infants, characterized by motor neuron degeneration.
- This condition often leads to profound paralysis and necessitates mechanical ventilation for survival.
- Children with SMA type 1 retain cognitive abilities despite severe physical impairment.
Purpose of the Study:
- To analyze the ethical arguments surrounding the provision of invasive mechanical ventilation for children with SMA type 1.
- To address concerns about potentially excessive care in the context of life-sustaining treatment.
- To examine the ethical landscape of invasive ventilation for SMA type 1, considering practices in countries like France.
Main Methods:
- Ethical argument analysis
- Review of clinical and ethical literature on pediatric neuromuscular diseases
- Examination of the specific context of invasive ventilation in France
Main Results:
- Ethical debates exist regarding the balance between prolonging life and the quality of life for children with SMA type 1.
- Concerns about 'unreasonably excessive care' are a significant factor in these ethical discussions.
- France's approach to tracheotomy and mechanical ventilation for SMA type 1 presents a unique case study.
Conclusions:
- Invasive ventilation for SMA type 1 involves complex ethical considerations for healthcare professionals, families, and society.
- A nuanced ethical framework is required to guide decisions about life-sustaining treatments in pediatric neuromuscular diseases.
- Further dialogue is needed to establish ethical consensus on managing SMA type 1, especially in regions with specific treatment practices.
Abstract:
Spinal muscular atrophy (SMA) type 1 is a genetic neuromuscular disease in children that leads to degeneration of spinal cord motor neurons. This sometimes results in severe muscular paralysis requiring mechanical ventilation to sustain the child's life. The onset of SMA type 1, the most severe form of the disease, is during the first year of life. These children become severely paralysed, but retain their intellectual capacity. Ethical concerns arise when mechanical ventilation becomes necessary for survival. When professionals assess the resulting life for the child and family, they sometimes fear it will result in unreasonably excessive care. The aim of this article is to present an analysis of ethical arguments that could support or oppose the provision of invasive ventilation in this population. This examination is particularly relevant as France is one of the few countries performing tracheotomies and mechanical ventilation for this condition.
Related Concept Videos
Oxygen Delivering System III: Tracheostomy and T-piece
Tracheostomy
A tracheostomy is a surgically created opening (stoma) in the anterior part of the trachea. It is used to establish a patient airway, bypass an upper airway obstruction, simplify the removal of secretions, permit long-term...
Tracheostomy: Procedure and Tubes
Tracheostomy tubes can be made of semiflexible plastic (polyurethane or silicone), rigid plastic, or metal, and they come in...
Trachea
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of the...
